Skip to main content
. 2012 Jul 31;4(4):741–747. doi: 10.3892/etm.2012.650

Table III.

Patient characteristics with respect to ACE gene I/D genotype.

Variables II+ID (n=155) DD (n=38) P-value
Males, n (%) 92 (59.4) 24 (63.2) 0.67
Age (years) 57.0±7.3 57.6±7.3 0.66
Body mass index (kg/m2) 25.0±2.8 25.4±3.0 0.45
Systolic blood pressure (mmHg) 120.8±11.3 124.4±11.7 0.08
Diastolic blood pressure (mmHg) 74.8±8.8 75.8±7.1 0.51
Fasting glucose (mmol/l) 5.15±0.59 5.25±0.50 0.34
Total cholesterol (mmol/l) 4.39±0.78 4.43±0.73 0.75
Triglycerides (mmol/l) 1.48±0.51 1.48±0.48 0.95
Blood urea nitrogen (mmol/l) 5.54±1.31 5.71± 1.38 0.50
Creatinine (μmol/l) 75.9±17.1 76.4±15.6 0.88
Uric acid (μmol/l) 331±72 335±72 0.73
Recurrence, n (%) 36 (23.2) 17 (44.7) 0.008
LV end-systolic diameter (mm) 29.6±4.8 29.7±3.8 0.92
LV end-diastolic diameter (mm) 48.0±4.2 48.2±4.2 0.79
Left atrial dimension (mm) 39.6±5.2 41.6±5.7 0.043
Septal wall thickness (mm) 9.0±1.1 9.1±1.0 0.66
Posterior wall thickness (mm) 8.7±1.1 8.8±0.9 0.56
LV ejection fraction (%) 62.8±4.9 61.1±5.5 0.052

LV, left ventricular; ACE, angiotensin-converting enzyme.